Results 1 - 20 of 62 in Emisphere Technologies
-
Emisphere to Present At Rodman & Renshaw 10th Annual Healthcare Conference
Emisphere Technologies, Inc. , a biopharmaceutical company that focuses on a unique and improved delivery of therapeutic molecules using its Eligen Technology, today announced that President and Chief Executive ...
Comment?
-
Emisphere Technologies, Inc. Announces 2008 Third Quarter Financial Results
Emisphere Technologies, Inc. today announced its financial results for the third quarter ended September 30, 2008.
Comment?
-
Emisphere Technologies, Inc. Announces Conference Call for 2008 Third Quarter Financial Results
Comtex CEDAR KNOLLS, N.J., Nov 4, 2008 ----Emisphere Technologies, Inc. will host a conference call discussing its financial results for the third quarter 2008 on Thursday, November 6, 2008 at 10:00 AM EST.
Comment?
-
Study Finds Improved Absorption of Oral Salmon Calcitonin Versus Nasal Administration
Emisphere Technologies, Inc. announced today that a study by Novartis Pharma AG and its partner Nordic Bioscience demonstrated that oral salmon calcitonin using Emisphere's proprietary Eligen Technology taken ...
Comment?
-
Emisphere Announces Publication of Independent Early-Stage Clinical...
Emisphere Technologies, Inc. today announced the publication of a study assessing the oral delivery of GLP-1 and PYY3-36 using Emisphere's proprietary delivery technology.
Comment?
-
Chemical building fire in Hawthorne quickly extinguished
... in a cleaning machine. He said about 60 people were evacuated from the building, which houses Emisphere Technologies. No injuries were reported. Firefighters from Hawthorne, Elmsford, Thornwood and Valhalla responded to the fire. 'They did a ...
Comment?
-
Emisphere Technologies, Inc. Q2 2008 Earnings Call Transcript
Emisphere Technologies, Inc. Q2 2008 Earnings Call August 11, 2008 10:00 am ET Executives Michael V. Novinski - President, Chief Executive Officer, Director Michael R. Garone - Chief Financial Officer, Vice ...
Comment?
-
Emisphere Announces Recruitment Phase III Study For Oral Osteoarthritis Treatment
Main Category: Arthritis / Rheumatology Also Included In: Bones / Orthopaedics ; Clinical Trials / Drug Trials ; Pharma Industry / Biotech Industry Article Date: 23 Sep 2008 - 0:00 PDT Emisphere Technologies, ...
Comment?
-
Emisphere Technologies Inc. (EMIS): Carl Icahn Initiates Holdings in EMIS
Pharmaceuticals Emisphere Technologies is a biopharmaceutical company focused on the development of a family of oral heparin products; the application of proprietary synthetic chemical compounds to serve as ...
Comment?
-
Carl Icahn Buys Yahoo! Inc., Motorola Inc., Emisphere Technologies...
GuruFocus Home >> News Home >> Carl Icahn Buys Yahoo! Inc., Motorola Inc., Emisphere Technologies Inc., Sells BEA Systems Inc., GUARANTY FIN GROUP, Perry Ellis International Inc.
Comment?
-
... one more. Icahn's investment firm Icahn Capital made a new investment in biopharmaceutical company Emisphere Technologies (nasdaq: EMIS - news - people ) during the second quarter, paying $232,000 for 86,430 shares, less than a 1.0% stake, according ...
Comment?
-
... forcing board chairman Thomas Curran to step in as interim CEO. In January, Interleukin named former Emisphere Technologies, Inc. executive Lewis H. Bender as CEO. Interleukin, which lists 27 workers, reported a 2007 net loss of $6.95 million, on ...
Comment?
-
Business in the Burbs: Cost cuts at Emisphere help reduce loss
Second-quarter losses at Emisphere Technologies Inc. narrowed as the company's 2007 decision to move management from Eastview to New Jersey and to cut staff helped reduce expenses.
Comment?
-
Emisphere Technologies, Inc. to Hold Conference Call to Announce 2008 ...
... to be Held Monday, August 11 at 10:00 AM EDT CEDAR KNOLLS, N.J., Aug. 7 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. (Nasdaq: EMIS ) will host a conference call to discuss second quarter results at 10:00 AM EDT Monday, August 11, 2008. A ...
Comment?
-
Emisphere Announces Recruitment Of Novartis Phase III Study For Oral Osteoporosis Treatment
Main Category: Bones / Orthopaedics Also Included In: Pharma Industry / Biotech Industry Emisphere Technologies, Inc.
Comment?
-
Business in the Burbs: Emisphere reports upbeat results in drug tests
Emisphere Technologies Inc. said yesterday that study results show an oral form of vitamin B-12 that the company is developing reduced the amount of time it took for the body to absorb the nutrient, while ...
Comment?
-
Business in the Burbs: Emisphere reports upbeat results in drug tests
Emisphere Technologies Inc. said yesterday that study results show an oral form of vitamin B-12 that the company is developing reduced the amount of time it took for the body to absorb the nutrient, while ...
Comment?
-
Emisphere Presents Dramatic Clinical Evidence Demonstrating New...
... results and future direction set for July 29 - CEDAR KNOLLS, N.J., July 28 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. (Nasdaq: EMIS ) today announced new human clinical data demonstrating a new, more bioavailable oral form Vitamin B12 ...
Comment?
-
Emisphere Announces Data From Independent Clinical Study Of Effects...
Emisphere Technologies, Inc. announced findings from a clinical study assessing the oral delivery of GLP-1 peptide safely and effectively.
Comment?
-
Emisphere Announces Data From Independent Clinical Study Of Effects...
Main Category: Diabetes Also Included In: Clinical Trials / Drug Trials ; Pharma Industry / Biotech Industry Article Date: 09 Jul 2008 - 1:00 PDT Emisphere Technologies, Inc.
Comment?
Emisphere Technologies Forum
Most Popular